
GlycoMimetics Inc (CBIO) P/E Ratio
P/E Ratio as of Jul 25, 2025: -0.29
Average-0.3100
Median-0.2900
Minimum-0.3700
Maximum-0.2600
-0.29
Past Month+0.10 (25.64%)
The P/E ratio for GlycoMimetics Inc (CBIO) is -0.29 as of Jul 25, 2025. This represents a decrease of -32.56% compared to its 12-month average P/E ratio of -0.43. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
GlycoMimetics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
GlycoMimetics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing GlycoMimetics Inc to industry peers.
GlycoMimetics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
GlycoMimetics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing GlycoMimetics Inc to industry peers.
GlycoMimetics Inc (CBIO) P/E Ratio Insights
See GlycoMimetics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in GlycoMimetics Inc (CBIO)
Order type
Buy in
Order amount
Est. shares
0 shares
GlycoMimetics Inc (CBIO) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $16.15 | -0.35 |
Jun 2, 2025 | $20.20 | -0.44 |
May 1, 2025 | $26.28 | -0.57 |
Apr 1, 2025 | $20.11 | -0.44 |
Mar 3, 2025 | $25.87 | -0.44 |
Feb 3, 2025 | $26.20 | -0.45 |
Jan 2, 2025 | $25.53 | -0.43 |
GlycoMimetics Inc (CBIO) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.29 | -30.95% |
2024 | -0.42 | -88.68% |
2023 | -3.71 | +26.19% |
2022 | -2.94 | +151.28% |
2021 | -1.17 | -65.49% |
2020 | -3.39 | — |
FAQs About GlycoMimetics Inc (CBIO) P/E ratio
The latest P/E ratio of GlycoMimetics Inc (CBIO) is -0.29, as of Jul 25, 2025. This is calculated based on its current stock price and earnings per share (EPS).
GlycoMimetics Inc’s last 12-month average P/E ratio is -0.43, compared to its current P/E ratio of -0.29. This reflects a decrease of -32.56%.
GlycoMimetics Inc’s current P/E ratio of -0.29 is lower than its last 12-month average P/E of -0.43. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
GlycoMimetics Inc’s average P/E ratio over the last 3 years is -1.73. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
GlycoMimetics Inc’s average P/E ratio over the last 5 years is -1.84. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.